Načítá se...
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
Inhaled fixed-dose combinations (FDCs) of a long-acting β-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) have become the cornerstone for the maintenance treatment of symptomatic COPD patients. In this regard, global COPD treatment guidelines have recognized the importance of inhaler d...
Uloženo v:
| Vydáno v: | Pulm Ther |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Healthcare
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6967354/ https://ncbi.nlm.nih.gov/pubmed/32026426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-019-0090-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|